|
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
RECRUITINGSponsored by Zimmer Biomet
Actively Recruiting
SponsorZimmer Biomet
Started2023-06-28
Est. completion2026-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT05787821
Summary
The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Patient is of legal age and skeletally mature 2. Patient is willing and able to provide written Informed Consent by signing and dating the Institutional Review Board (IRB) / Ethics Committee (EC) approved Informed Consent document 3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol 4. Independent of study participation, patient qualifies for either cemented or cementless primary or revision total knee arthroplasty (including salvage of previously failed surgical attempts) based upon physical exam and medical history, and meets the approved indications for use of the commercially available Persona Knee System with appropriately matched Zimmer Biomet components implanted in accordance with product labeling Exclusion Criteria: 1. Patient is currently participating in any other surgical intervention or pain management study 2. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent) 3. Patient has a mental or neurological condition who is unwilling or incapable of following postoperative care instructions 4. Patient has a condition which would, in the judgment of the investigator, place the patient at undue risk or interfere with the conduct of the study 5. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation 6. Patient is scheduled to undergo simultaneous bilateral total knee arthroplasty 7. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint 8. Insufficient bone stock on femoral or tibial surfaces 9. Neuropathic arthropathy 10. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb 11. A stable, painless arthrodesis in a satisfactory functional position 12. Severe instability secondary to the absence of collateral ligament integrity 13. Rheumatoid Arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin 14. Patient has a \> 5˚ valgus deformity with a medial collateral ligament (MCL) insufficiency, and the surgeon intends to use the personalized alignment surgical technique
Conditions10
ArthritisAvascular NecrosisFlexion Deformity of KneeKnee Pain ChronicOsteoarthritis, KneePolyarthritisRheumatoid ArthritisTraumatic ArthritisValgus DeformityVarus Deformity
Locations16 sites
Denver Hip & Knee, Inc.
Parker, Colorado, 80138
Amy Gridley
Foundation for Orthopaedic Research & Education
Tampa, Florida, 33607
Anne Meredith Baldy
Northside Hospital, Inc.
Atlanta, Georgia, 30342
U of L Health
Louisville, Kentucky, 40202
Langan Smith
University of Michigan
Ann Arbor, Michigan, 48109
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorZimmer Biomet
Started2023-06-28
Est. completion2026-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT05787821